Generating New Blood Flow: Integrating Developmental Biology and Tissue Engineering

Trends in Cardiovascular Medicine

Volumn 18, Issue 8, 2008, Pages 312-323

  Krenning, Guido ^a   Moonen, Jan Renier A J ^a   van Luyn, Marja J A ^a   Harmsen, Martin C ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

CELL MIGRATION; CELL TRANSDIFFERENTIATION; ENDOTHELIUM CELL; MESENCHYME CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; VASCULAR TISSUE;

BLOOD VESSEL PROSTHESIS; CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HUMANS; MESODERM; MUSCLE, SMOOTH, VASCULAR; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA; VASCULAR DISEASES;

EID: 63449141615     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2009.01.004     Document Type: Review

References (97)

1. Alobaid N., Salacinski H.J., Sales K.M., et al. Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. Eur J Vasc Endovasc Surg 32 (2006) 76-83
2. Arciniegas E., Frid M.G., Douglas I.S., and Stenmark K.R. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 293 (2007) L1-L8
3. Arciniegas E., Neves Y.C., and Carrillo L.M. Potential role for insulin-like growth factor II and vitronectin in the endothelial-mesenchymal transition process. Differentiation 74 (2006) 277-292
4. Arciniegas E., Ponce L., Hartt Y., et al. Intimal thickening involves transdifferentiation of embryonic endothelial cells. Anat Rec 258 (2000) 47-57
5. Armstrong E.J., and Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res 95 (2004) 459-470
6. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
7. Benchabane H., and Wrana J.L. GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations. Mol Cell Biol 23 (2003) 6646-6661
8. Botta R., Gao E., Stassi G., et al. Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J 18 (2004) 1392-1394
9. Brody S., Anilkumar T., Liliensiek S., et al. Characterizing nanoscale topography of the aortic heart valve basement membrane for tissue engineering heart valve scaffold design. Tissue Eng 12 (2006) 413-421
10. Calera M.R., Venkatakrishnan A., and Kazlauskas A. VE-cadherin increases the half-life of VEGF receptor 2. Exp Cell Res 300 (2004) 248-256
11. Camoretti-Mercado B., Fernandes D.J., Dewundara S., et al. Inhibition of transforming growth factor b-enhanced serum response factor-dependent transcription by SMAD7. J Biol Chem 281 (2006) 20383-20392
12. Chen C.N., Li Y.S., Yeh Y.T., et al. Synergistic roles of platelet-derived growth factor-BB and interleukin-1b in phenotypic modulation of human aortic smooth muscle cells. Proc Natl Acad Sci U S A 103 (2006) 2665-2670
13. Choi J.S., Lee S.J., Christ G.J., et al. The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials 29 (2008) 2899-2906
14. Couet F., Rajan N., and Mantovani D. Macromolecular biomaterials for scaffold-based vascular tissue engineering. Macromol Biosci 7 (2007) 701-718
15. Deguchi J., Namba T., Hamada H., et al. Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther 6 (1999) 956-965
16. Deissler H., Deissler H., Lang G.K., and Lang G.E. TGFb induces transdifferentiation of iBREC to aSMA-expressing cells. Int J Mol Med 18 (2006) 577-582
17. Duong T.D., and Erickson C.A. MMP-2 plays an essential role in producing epithelial-mesenchymal transformations in the avian embryo. Dev Dyn 229 (2004) 42-53
18. Feng Y., and Mrksich M. The synergy peptide PHSRN and the adhesion peptide RGD mediate cell adhesion through a common mechanism. Biochemistry 43 (2004) 15811-15821
19. Ferrari G., Pintucci G., Seghezzi G., et al. VEGF, a prosurvival factor, acts in concert with TGF-b1 to induce endothelial cell apoptosis. Proc Natl Acad Sci U S A 103 (2006) 17260-17265
20. Ferreira L.S., Gerecht S., Fuller J., et al. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 28 (2007) 2706-2717
21. Frank R., mann-Grill B.C., Herrmann K., et al. Transforming growth factor-b controls cell-matrix interaction of microvascular dermal endothelial cells by downregulation of integrin expression. J Invest Dermatol 106 (1996) 36-41
22. Fujiyama S., Amano K., Uehira K., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 93 (2003) 980-989
23. Gnecchi M., Zhang Z., Ni A., and Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103 (2008) 1204-1219
24. Gong Y., He L., Li J., et al. Hydrogel-filled polylactide porous scaffolds for cartilage tissue engineering. J Biomed Mater Res B Appl Biomater 82 (2007) 192-204
25. Grant D.S., Tashiro K.I., Segui-Real B., et al. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58 (1989) 933-943
26. Ha C.H., Bennett A.M., and Jin Z.G. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J Biol Chem 283 (2008) 7261-7270
27. Hall S.M., Hislop A.A., and Haworth S.G. Origin, differentiation, and maturation of human pulmonary veins. Am J Respir Cell Mol Biol 26 (2002) 333-340
28. Hao H., Ropraz P., Verin V., et al. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol 22 (2002) 1093-1099
29. Hautmann M.B., Madsen C.S., and Owens G.K. A transforming growth factor beta (TGFb) control element drives TGFb-induced stimulation of smooth muscle a-actin gene expression in concert with two CArG elements. J Biol Chem 272 (1997) 10948-10956
30. Herbrig K., Pistrosch F., Oelschlaegel U., et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 44 (2004) 840-849
31. Hill J., Zalos G., Halcox J., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
32. Hocking D.C., Sottile J., and McKeown-Longo P.J. Activation of distinct a5b1-mediated signaling pathways by fibronectin's cell adhesion and matrix assembly domains. J Cell Biol 141 (1998) 241-253
33. Hyman K.M., Seghezzi G., Pintucci G., et al. Transforming growth factor-b1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery 132 (2002) 173-179
34. Igreja C., Fragoso R., Caiado F., et al. Detailed molecular characterization of cord blood-derived endothelial progenitors. Exp Hematol 36 (2008) 193-203
35. Ingram D., Mead L., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells utilizing human peripheral and umbilical cord blood. Blood 104 (2004) 2752-2760
36. Isenberg B.C., Tsuda Y., Williams C., et al. A thermoresponsive, microtextured substrate for cell sheet engineering with defined structural organization. Biomaterials 29 (2008) 2565-2572
37. Ishihara H., Kubota H., Lindberg R.L., et al. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor b2 involves matrix metalloproteinases and tight junction proteins. J Neuropathol Exp Neurol 67 (2008) 435-448
38. Ishisaki A., Hayashi H., Li A.J., and Imamura T. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem 278 (2003) 1303-1309
39. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
40. Kannan R.Y., Salacinski H.J., Butler P.E., et al. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater 74 (2005) 570-581
41. Kawamoto A., and Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Interv 70 (2007) 477-484
42. Kawamoto A., and Losordo D.W. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 18 (2008) 33-37
43. Kilian O., Flesch I., Wenisch S., et al. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur J Med Res 9 (2004) 337-344
44. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94 (2004) 678-685
45. Koshida R., Rocic P., Saito S., et al. Role of focal adhesion kinase in flow-induced dilation of coronary arterioles. Arterioscler Thromb Vasc Biol 25 (2005) 2548-2553
46. Krenning G., Dankers P.Y.W., Jovanovic D., et al. Efficient differentiation of CD14+ monocytic cells into endothelial cells on degradable biomaterials. Biomaterials 28 (2007) 1470-1479
47. Krenning G., Van Der Strate B.W.A., Schipper M., et al. CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J Cell Mol Med (2008) In press
48. Krenning G., Moonen J.R., van Luyn M.J.A., and Harmsen M.C. Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials 29 (2008) 3703-3711
49. Krug E.L., Mjaatvedt C.H., and Markwald R.R. Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. Dev Biol 120 (1987) 348-355
50. Lampugnani M.G., Orsenigo F., Gagliani M.C., et al. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 174 (2006) 593-604
51. Lee Y.H., Kayyali U.S., Sousa A.M., et al. Transforming growth factor-b1 effects on endothelial monolayer permeability involve focal adhesion kinase/Src. Am J Respir Cell Mol Biol 37 (2007) 485-493
52. Li L., Miano J.M., Mercer B., and Olson E.N. Expression of the SM22a promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 132 (1996) 849-859
53. Li X., Van Putten V., Zarinetchi F., et al. Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2. Biochem J 327 (1997) 709-716
54. Liebner S., Cattelino A., Gallini R., et al. b-Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol 166 (2004) 359-367
55. Lin Y.K., and Liu D.C. Studies of novel hyaluronic acid-collagen sponge materials composed of two different species of type I collagen. J Biomater Appl 21 (2007) 265-281
56. Malmstrom J., Lindberg H., Lindberg C., et al. Transforming growth factor-b1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics 3 (2004) 466-477
57. Mercado-Pimentel M.E., Hubbard A.D., and Runyan R.B. Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 304 (2007) 420-432
58. Miyata T., Iizasa H., Sai Y., et al. Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J Cell Physiol 204 (2005) 948-955
59. Moonen J.R.A.J., de Leeuw K., van Seijen X., et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 9 (2007) R84
60. Nagai R., Suzuki T., Aizawa K., et al. Phenotypic modulation of vascular smooth muscle cells: dissection of transcriptional regulatory mechanisms. Ann N Y Acad Sci 947 (2001) 56-66
61. Nillesen S.T., Geutjes P.J., Wismans R., et al. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28 (2007) 1123-1131
62. Noseda M., McLean G., Niessen K., et al. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res 94 (2004) 910-917
63. O'Riordan E., Mendelev N., Patschan S., et al. Chronic NOS inhibition actuates endothelial-mesenchymal transformation. Am J Physiol Heart Circ Physiol 292 (2007) H285-H294
64. Olson E.N., Perry M., and Schulz R.A. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev Biol 172 (1995) 2-14
65. Olsson A.K., Dimberg A., Kreuger J., and Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 7 (2006) 359-371
66. Paranya G., Vineberg S., Dvorin E., et al. Aortic valve endothelial cells undergo transforming growth factor-b-mediated and non-transforming growth factor-b-mediated transdifferentiation in vitro. Am J Pathol 159 (2001) 1335-1343
67. Pike D., Cai S., Pomraning K., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27 (2006) 5242-5251
68. Pollman M.J., Naumovski L., and Gibbons G.H. Vascular cell apoptosis: cell type specific modulation by transforming growth factor-β1 in endothelial cells versus smooth muscle cells. Circulation 99 (1999) 2019-2026
69. Reddy K., and Mangale S.S. Integrin receptors: the dynamic modulators of endometrial function. Tissue Cell 35 (2003) 260-273
70. Rensen S.S., Doevendans P.A., and van Eys G.J. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15 (2007) 100-108
71. Rohde E., Malischnik C., Thaler D., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 24 (2006) 357-367
72. Sakao S., Taraseviciene-Stewart L., Cool C., et al. VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells. FASEB J 21 (2007) 3640-3652
73. Sarkar S., Lee G.Y., Wong J.Y., and Desai T.A. Development and characterization of a porous micro-patterned scaffold for vascular tissue engineering applications. Biomaterials 27 (2006) 4775-4782
74. Seliktar D., Zisch A.H., Lutolf M.P., et al. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. J Biomed Mater Res A 68 (2004) 704-716
75. Shadwick R.E. Mechanical design in arteries. J Exp Biol 202 (1999) 3305-3313
76. Sinha S., Hoofnagle M.H., Kingston P.A., et al. Transforming growth factor-b1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 287 (2004) C1560-C1568
77. Smadja D.M., Basire A., Amelot A., et al. Thrombin bound to a fibrin clot confers angiogenic and hemostatic properties on endothelial progenitor cells. J Cell Mol Med 12 (2008) 975-986
78. Song W., Jackson K., and McGuire P.G. Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions. Dev Biol 227 (2000) 606-617
79. Taipale J., and Keski-Oja J. Growth factors in the extracellular matrix. FASEB J 11 (1997) 51-59
80. Takahashi M., Li T.S., Suzuki R., et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 291 (2006) H886-H893
81. Tanaka T., Saika S., Ohnishi Y., et al. Fibroblast growth factor 2: roles of regulation of lens cell proliferation and epithelial-mesenchymal transition in response to injury. Mol Vis 10 (2004) 462-467
82. Tei K., Matsumoto T., Mifune Y., et al. Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis. Stem Cells (2008) 2007-2671
83. Thomas V., Jose M.V., Chowdhury S., et al. Mechano-morphological studies of aligned nanofibrous scaffolds of polycaprolactone fabricated by electrospinning. J Biomater Sci Polym Ed 17 (2006) 969-984
84. Tsilibary E.C., Reger L.A., Vogel A.M., et al. Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen. J Cell Biol 111 (1990) 1583-1591
85. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) e1-e7
86. Vasita R., Shanmugam I.K., and Katt D.S. Improved biomaterials for tissue engineering applications: surface modification of polymers. Curr Top Med Chem 8 (2008) 341-353
87. Yamamoto M., Yamamoto K., and Noumura T. Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype. Exp Cell Res 204 (1993) 121-129
88. Yoder M., Mead L., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
89. Yoon C., Hur J., Park K., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112 (2005) 1618-1627
90. Zamora P.O., Eshima D., Graham D., et al. Biological distribution of 99mTc-labeled YIGSR and IKVAV laminin peptides in rodents: 99mTc-IKVAV peptide localizes to the lung. Biochim Biophys Acta 1182 (1993) 197-204
91. Zeisberg E.M., Tarnavski O., Zeisberg M., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13 (2007) 952-961
92. Zentilin L., Taturo S., Zacchigna S., et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 107 (2006) 3546-3554
93. Zhang S.J., Zhang H., Wei Y.J., et al. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res 16 (2006) 577-584
94. Zhang X.F., Groopman J.E., and Wang J.F. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin a5b1. J Cell Physiol 202 (2005) 205-214
95. Zilberman A., Dave V., Miano J., et al. Evolutionarily conserved promoter region containing CArG-like elements is crucial for smooth muscle myosin heavy chain gene expression. Circ Res 82 (1998) 566-575
96. Zisch A., Lutolf M., and Hubbell J. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12 (2003) 295-310
97. Zisch A.H., Lutolf M.P., Ehrbar M., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. FASEB J 17 (2003) 2260-2262